Anca Jurj

Sensitizer drugs for the treatment of temozolomide-resistant glioblastoma.

C. Braicu, O. Sorițău, C. Tomuleasa, 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Fibroblast dynamics as an in vitro screening platform for anti‐fibrotic drugs in primary myelofibrosis

I. Berindan‐Neagoe, Lorand Magdo, S. Pașca, 2018, Journal of cellular physiology.

SERS assessment of the cancer-specific methylation pattern of genomic DNA: towards the detection of acute myeloid leukemia in patients undergoing hematopoietic stem cell transplantation

N. Leopold, R. Tetean, C. Tomuleasa, 2019, Analytical and Bioanalytical Chemistry.

Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches

I. Berindan‐Neagoe, S. Pașca, B. Petrushev, 2018, Critical reviews in clinical laboratory sciences.

Caffeic acid phenethyl ester activates pro-apoptotic and epithelial–mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis

I. Berindan‐Neagoe, C. Braicu, V. Pileczki, 2016, Molecular and Cellular Biochemistry.

A New Detection Method of Oral and Oropharyngeal Squamous Cell Carcinoma Based on Multivariate Analysis of Surface Enhanced Raman Spectra of Salivary Exosomes

R. Marginean, V. Toma, R. Știufiuc, 2023, Journal of personalized medicine.